Mark G. Kris, MD, is an Attending Physician in the Thoracic Oncology Service at Memorial Hospital, Division of Solid Tumor Oncology, Department of Medicine, at Memorial Sloan Kettering Cancer Center in New York, NY. He is the first incumbent of the William and Joy Ruane Chair in Thoracic Oncology. Dr. Kris is also a Professor of Medicine at Weill Cornell Medical College.
Dr. Kris received his medical degree from Weill Cornell Medical College, completed his residency and fellowship in medical oncology at Memorial Sloan Kettering Cancer Center, and then joined the attending staff there in 1983.
To date, Dr. Kris has served as the author or coauthor of over 500 scientific publications. He serves as a member of the guideline panel on antiemetics for the National Comprehensive Cancer Center Network. He also serves as co-chair of the American Society of Clinical Oncology guideline panels for adjuvant chemotherapy and radiation for non-small cell lung cancers and antiemetics. Dr. Kris is a fellow of the American College of Physicians, the American College of Chest Physicians, and the American Society of Clinical Oncology. He has been honored with several awards, including the first American Society of Clinical Oncology Humanitarian Award in 2011; the Annie Blount Storrs Award from Calvary Hospital in 2014; and the Willet F. Whitmore Award for Clinical Excellence from Memorial Sloan Kettering in 2021.
Dr. Kris is a specialist in lung cancers. He is particularly interested in developing ways to choose treatments for patients based on molecular characteristics of their tumor specimens. His research also includes the evaluation of new anticancer agents (particularly those targeting lung cancers) and multimodality therapy (using surgery, radiation, and drugs together to improve outcomes for individuals with thoracic cancers).